ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL CAN REAL - - PowerPoint PPT Presentation

atrial fibrillation stroke insights tool
SMART_READER_LITE
LIVE PREVIEW

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL CAN REAL - - PowerPoint PPT Presentation

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL CAN REAL WORLD/PUBLICALLY AVAILABLE DATA COUPLED WITH TTR DATA HELP THE NHS STOP STROKES? Andrzei Orlowski - Programme Development Lead for Health and Implementation Andrzei Orlowski -


slide-1
SLIDE 1

ATRIAL FIBRILLATION & STROKE INSIGHTS TOOL –

CAN REAL WORLD/PUBLICALLY AVAILABLE DATA COUPLED WITH TTR DATA HELP THE NHS STOP STROKES?

Andrzei Orlowski - Programme Development Lead for Health and Implementation (Stroke and Atrial Fibrillation) Andrzei Orlowski - Programme Development Lead for Health and Implementation (Stroke and Atrial Fibrillation)

slide-2
SLIDE 2

GREATER MANCHESTER ACADEMIC HEALTH SCIENCE NETWORK

Greater Manchester AHSN is a collaborative network bringing together 30 NHS providers and commissioners across Greater Manchester, East Lancashire Trust and East Cheshire and four universities. Our ambition is to deliver a step change in health

  • utcomes and to support Greater Manchester's strategy

for growth through enabling £1bn of wealth creation

  • ver five years, supporting SMEs and helping to create a

healthier population.

slide-3
SLIDE 3

ATRIAL FIBRILLATION & AF RELATED STROKE HEALTH AND IMPLEMENTATION PROGRAMME Our Goal is to help prevent at least 365 deaths from avoidable strokes each year AF implementation programme is encouraging

  • ur members to prioritise AF and the adoption of

NICE guideline CG180 (The Management of Atrial Fibrillation).

slide-4
SLIDE 4

SHARE DATA Reflect our members data back Equal and equitable access Discuss variation with a fair comparison

  • Percentage
  • Absolute numbers
  • Per 100k population
  • ONS matched
  • PHE matched
slide-5
SLIDE 5

PREVALENCE AND INCIDENCE

*Publically available data *Publically available data

Quality Outcomes Framework* (QOF)

  • AF disease register
  • Stroke register
slide-6
SLIDE 6

THE NUMBER AND COST OF STROKE

*Publically available data *Publically available data

Hospital Episode Statistics* (HES)

slide-7
SLIDE 7

PATHWAY OF CARE

*Publically available data *Publically available data

Hospital Episode Statistics* (HES)

  • Admission route
  • From where to where
  • Discharge destination – to home or to a home
slide-8
SLIDE 8

RISK STRATIFICATION AND TREATMENT

*Publically available data *Publically available data

Quality Outcome Framework*

slide-9
SLIDE 9

DATA ON THOSE THAT HAVE A STROKE

*Publically available data *Publically available data

Sentinel Stroke National Audit Programme* (SSNAP)

slide-10
SLIDE 10

APPROPRIATE TREATMENT OF THOSE AT RISK

*Available from NHS IQ *Available from NHS IQ

GRASP-AF*

  • Read code data interrogation tool
  • Helps to find patients that could benefit from anti-

coagulation treatment

slide-11
SLIDE 11

TREATMENT

*Publically available data *Publically available data

ePACT (electronic Prescribing Analysis and CosT)*

  • By drug
  • By pack
  • By practice
  • Great for NOACs
  • Useless for warfarin and aspirin
slide-12
SLIDE 12

TREATMENT ePACT (electronic Prescribing Analysis and CosT) Drug By pack By practice Great for NOACs Useless for warfarin and aspirin Publically available data

slide-13
SLIDE 13

TREATMENT

slide-14
SLIDE 14

THE MISSING PIECE - ANTICOAGULATION CONTROL WITH VITAMIN K ANTAGONISTS Numbers of patients being treated

  • HES
  • Outpatients only recorded by speciality not by specific
  • utpatient clinic
  • Very little OPCS coding for INR testing
  • QOF
  • Data on those on anticoagulation only (and those have to

be registered and have had an appropriate CHADS2 score)

  • ePACT
  • Numbers of tablets dispensed only

QOF CHADS2 being treated – NOAC = warfarin patients?

slide-15
SLIDE 15

THE MISSING PIECE - ANTICOAGULATION CONTROL WITH VITAMIN K ANTAGONISTS Patients in range

  • ….
slide-16
SLIDE 16

THE MISSING PIECE - ANTICOAGULATION CONTROL WITH VITAMIN K ANTAGONISTS NICE Guidance (CG180)

  • 2 INR values higher than 5 or 1 INR value higher than

8 within the past 6 months?

  • 2 INR values less than 1.5 within the past 6 months?
  • TTR less than 65%?
  • But I think I know who may have the answers…
slide-17
SLIDE 17

PARTNERING ON DATA By sharing your appropriately aggregated and anonymised data you can help create a tool that may help CCGs prevent deaths by allowing them to allocate resources to the most appropriate areas

slide-18
SLIDE 18

PARTNERING ON DATA

  • We currently have data on >22,000 patients

from 12 4SDAWN sites in Manchester and we are looking for more

  • More data helps us compare ‘apples with

apples’

  • Our tool has national data and is being offered

to all AHSN and any appropriate interested NHS organisation

slide-19
SLIDE 19

CAN REAL WORLD AND PUBLICALLY AVAILABLE DATA COUPLED WITH YOUR TTR DATA HELP THE NHS STOP STROKES?

slide-20
SLIDE 20

BY HAVING THE COMPLETE PICTURE

*Publically available data *Publically available data

CCGs can pick the most appropriate area

  • Screening
  • Pathway change
  • Earlier treatment
  • Treatment change
slide-21
SLIDE 21

Questions?

andi.orlowski@gmahsn.org AF Programme lead jane.macdonald@gmahsn.org Director of Implementation